Category: Press Release - Page 160 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

Post published:January 28, 2021
Post category:Press Release

Read more about the article BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

Post published:January 28, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Files Application to list to the NASDAQ

Mydecine Innovations Group Files Application to list to the NASDAQ

Post published:January 27, 2021
Post category:Press Release

Read more about the article NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer

NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer

Post published:January 27, 2021
Post category:Press Release

Read more about the article Psyence Group to Commence Trading (CSE:PSYG) on January 27, 2021

Psyence Group to Commence Trading (CSE:PSYG) on January 27, 2021

Post published:January 26, 2021
Post category:Press Release

Read more about the article atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents

atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents

Post published:January 26, 2021
Post category:Press Release

Read more about the article Novamind Announces Marketing Services Agreements

Novamind Announces Marketing Services Agreements

Post published:January 26, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category

MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category

Post published:January 26, 2021
Post category:Press Release

Read more about the article Silo Pharma Reaches Terms with University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Silo Pharma Reaches Terms with University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Post published:January 26, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US

Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US

Post published:January 26, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.